October 30, 2026, 10:00 AM – 11:00 AM ET

Partner Circle Program
Many biotech and pharmaceutical companies find themselves in a “good news–bad news” situation: Positive late-phase clinical data and a potentially registrational product, but little or no prior investment in establishing a Medical Affairs function. This webinar will explore how to build a Medical Affairs organization from scratch and accelerate its development into a high-performing, launch-ready team. Participants will learn how Medical Affairs can support the 4As of Approval, Access, Advocacy, and Adoption while focusing on the 3Ps: Preparing the Product, Preparing the Market, and Preparing the Company.
Attendees will gain practical insights into capability building, organizational design, prioritization, and execution, enabling Medical Affairs to move rapidly from foundational activities to delivering strategic impact.
Learning Objectives
- Understand the essential components, capabilities, and operating model needed to build a Medical Affairs function from the ground up and evolve it into a launch-ready organization
- Evaluate how Medical Affairs can strategically support the 4As—Approval, Access, Advocacy, and Adoption—by aligning priorities and deliverables to the 3Ps: Preparing the Product, Preparing the Market, and Preparing the Company
- Apply a practical roadmap for sequencing “foundational-to-strategic” Medical Affairs activities across late-phase development through launch, including what to do first, what to defer, and what to stop
- Understand the fundamentals of designing an initial Medical Affairs organizational structure and resourcing plan that balances strategic contribution with medical governance
Speakers

Executive Vice President, Medical Strategy
Lumanity

Head of Medical Affairs Oncology, EU & Canada
Daiichi Sankyo Europe GmbH

Senior Vice President, Head of Medical Affairs
Apellis Pharmaceuticals